“Can I begin an investigator-initiated small business application now? It looks like the funding opportunity announcement is expired.”

Funding News Edition: June 01, 2022
See more articles in this edition

NIH reissues the parent small business technology transfer (R41/R42) and small business innovation research (R43/R44) funding opportunity announcements (FOAs) annually, typically in early July. If you are planning to apply for the next Standard Due Date on September 5, 2022, you need to wait for NIH to reissue the parent R41/R42 and R43/R44 FOAs.

Find additional details at Notice of Intent to Publish a Funding Opportunity Announcement for PHS 2022-2 Omnibus Solicitations of the NIH, CDC, and FDA for Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Grant Applications. Note that NIAID accepts clinical trial applications from small businesses through NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44, Clinical Trial Required), rather than the parent FOAs.

Contact Us

Email us at deaweb@niaid.nih.gov for help navigating NIAID’s grant and contract policies and procedures.

Content last reviewed on